Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Human mesenchymal stem cells (MSCs) are multipotent progenitor cells capable of differentiating into osteoblasts, adipocytes, and chondrocytes. MSC fate and function are tightly regulated by the extracellular matrix (ECM) microenvironment, which provides critical biochemical and biomechanical cues. These signals are transmitted through cell surface receptors such as integrins, activating intracellular signaling pathways (e.g., ERK/MAPK, FAK, YAP/beta-catenin) that determine proliferation, differentiation, and tissue repair capacity. MSCs and their interactions with the ECM are central to tissue regeneration and are being explored in diverse therapeutic settings, but neither MSCs nor the ECM are themselves conventional single-molecule drug targets. Rather, the ECM functions as a dynamic regulatory platform that influences cell behavior and therapy outcomes.
Not applicable in the conventional sense. When used therapeutically, MSCs function via paracrine signaling, immunomodulation, and supporting tissue repair. In regenerative medicine, the ECM microenvironment influences their fate via signal transduction through integrins and growth factor receptors (e.g., ERK/MAPK pathways).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human mesenchymal stem cell (MSC).